These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21312051)

  • 1. Vasopressin analogues and V1a receptor agonists in septic shock.
    Maybauer MO; Maybauer DM
    Inflamm Res; 2011 May; 60(5):425-7. PubMed ID: 21312051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Singer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Lange M; Ertmer C; Westphal M
    Intensive Care Med; 2008 May; 34(5):821-32. PubMed ID: 18066524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience.
    Papoff P; Mancuso M; Barbara CS; Moretti C
    Int J Immunopathol Pharmacol; 2007; 20(2):213-21. PubMed ID: 17624234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF; Maybauer MO
    J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
    Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; Di Russo A; D'Egidio A; Landoni G; Lombrano MR; Botticelli L; Valentini A; Zangrillo A; Pietropaoli P; Westphal M
    Crit Care; 2011; 15(5):R217. PubMed ID: 21929764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.
    Morelli A; Ertmer C; Pietropaoli P; Westphal M
    Expert Opin Pharmacother; 2009 Oct; 10(15):2569-75. PubMed ID: 19735216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine-vasopressin in severe forms of septic shock.
    Meyer S; Shamdeen G; Gottschling S; Gortner L
    J Pediatr (Rio J); 2007; 83(4):389; author reply 387-8. PubMed ID: 17676247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vasopressin and its analogues in the therapy of shock].
    Novák F; Lubanda H; Onderková R; Zák A
    Cas Lek Cesk; 2004; 143(5):307-8, 310-2. PubMed ID: 15305765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review: Vasopressin and terlipressin in septic shock patients.
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
    Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G
    Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
    Leone M; Martin C
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin: vasopressin analog and novel drug for septic shock.
    Pesaturo AB; Jennings HR; Voils SA
    Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
    Rehberg S; Ertmer C; Köhler G; Spiegel HU; Morelli A; Lange M; Moll K; Schlack K; Van Aken H; Su F; Vincent JL; Westphal M
    Intensive Care Med; 2009 Jul; 35(7):1286-96. PubMed ID: 19360396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of non-adrenergic vasopressors on macro- and microvascular coupling in distributive shock.
    Hessler M; Kampmeier TG; Rehberg S
    Best Pract Res Clin Anaesthesiol; 2016 Dec; 30(4):465-477. PubMed ID: 27931650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin as rescue treatment of refractory shock in a neonate.
    Filippi L; Poggi C; Serafini L; Fiorini P
    Acta Paediatr; 2008 Apr; 97(4):500-2. PubMed ID: 18307552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
    Morelli A; Donati A; Ertmer C; Rehberg S; Orecchioni A; Di Russo A; Pelaia P; Pietropaoli P; Westphal M
    Intensive Care Med; 2011 Jun; 37(6):963-9. PubMed ID: 21336777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.